GHIGLIERI, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 2.450
AS - Asia 1.855
EU - Europa 714
SA - Sud America 264
Continente sconosciuto - Info sul continente non disponibili 143
AF - Africa 56
OC - Oceania 11
Totale 5.493
Nazione #
US - Stati Uniti d'America 2.248
SG - Singapore 540
CN - Cina 522
IT - Italia 371
TR - Turchia 352
BR - Brasile 212
VN - Vietnam 185
CA - Canada 175
DE - Germania 93
HK - Hong Kong 57
GB - Regno Unito 56
FR - Francia 52
IN - India 36
PK - Pakistan 36
BD - Bangladesh 23
IE - Irlanda 22
NL - Olanda 22
EU - Europa 20
MX - Messico 18
AR - Argentina 17
IL - Israele 17
RU - Federazione Russa 17
ZA - Sudafrica 17
PL - Polonia 13
JP - Giappone 12
CO - Colombia 11
IQ - Iraq 11
ES - Italia 10
ID - Indonesia 10
MA - Marocco 10
RO - Romania 10
SE - Svezia 10
EC - Ecuador 9
UA - Ucraina 9
FI - Finlandia 8
TW - Taiwan 8
AU - Australia 7
SA - Arabia Saudita 7
CL - Cile 6
KE - Kenya 6
PH - Filippine 6
TN - Tunisia 5
UZ - Uzbekistan 5
JO - Giordania 4
LT - Lituania 4
MY - Malesia 4
NZ - Nuova Zelanda 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
EG - Egitto 3
GR - Grecia 3
PE - Perù 3
PS - Palestinian Territory 3
RS - Serbia 3
SC - Seychelles 3
SN - Senegal 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
CR - Costa Rica 2
DK - Danimarca 2
JM - Giamaica 2
KR - Corea 2
LK - Sri Lanka 2
LY - Libia 2
NI - Nicaragua 2
PY - Paraguay 2
VE - Venezuela 2
AO - Angola 1
AT - Austria 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
CU - Cuba 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
MM - Myanmar 1
MR - Mauritania 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
TH - Thailandia 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 5.370
Città #
San Jose 361
Kocaeli 269
San Mateo 229
Ashburn 221
Rome 221
Singapore 185
Dallas 155
Toronto 151
Council Bluffs 130
Santa Clara 114
Beijing 105
Houston 93
Lawrence 79
Princeton 79
Wilmington 77
Ho Chi Minh City 65
Chandler 63
Hong Kong 54
Hanoi 45
Frankfurt am Main 38
Fairfield 33
Chicago 32
Islamabad 32
Shanghai 32
Los Angeles 28
Munich 25
New York 24
Redwood City 23
Guangzhou 22
Woodbridge 22
Assago 18
Seattle 18
The Dalles 18
Netanya 16
São Paulo 15
Shenzhen 14
Amsterdam 12
Columbus 12
Dublin 12
Brooklyn 11
Johannesburg 11
Mexico City 11
Ningbo 11
Orem 11
Chennai 10
Constanta 10
Falls Church 10
Tokyo 10
West Jordan 10
Jiaxing 9
Milan 9
Rio de Janeiro 9
Boston 8
Haiphong 8
Stockholm 8
Wroclaw 8
Biên Hòa 7
Cambridge 7
London 7
Montreal 7
Roubaix 7
Belo Horizonte 6
Da Nang 6
Dhaka 6
Helsinki 6
Mumbai 6
Taipei 6
Bexley 5
Bristol 5
Cagliari 5
Guayaquil 5
Moscow 5
Pune 5
Suffern 5
Tashkent 5
Trento 5
Amman 4
Atlanta 4
Baghdad 4
Charlotte 4
Curitiba 4
Guarulhos 4
Hải Dương 4
Jakarta 4
Kuala Lumpur 4
Manaus 4
Medellín 4
Nairobi 4
Quảng Ngãi 4
Rui'an 4
Salvador 4
Santiago 4
Wuhan 4
Wuxi 4
Belém 3
Boardman 3
Buffalo 3
Calgary 3
Casablanca 3
Chapadinha 3
Totale 3.512
Nome #
Direct and indirect pathways of basal ganglia: a critical reappraisal 238
Motor learning and metaplasticity in striatal neurons: relevance for Parkinson's disease 106
Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism. 97
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuo-spatial memory alteration. 86
Dopamine drives binge-like consumption of a palatable food in experimental parkinsonism. 82
Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms 79
Corticostriatal synaptic plasticity alterations in the R6/1 transgenic mouse model of Huntington's disease 78
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. 77
Interaction between basal ganglia and limbic circuits in learning and memory processes 76
Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N-Methyl-D-Aspartate Receptor Subunit 76
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap 73
Striatal spreading depolarization: possible implication in L-DOPA-induced dyskinetic like-behavior. 73
NMDA receptor G1uN2D subunit participates to levodopa-induced dyskinesia pathophysiology 70
Serotonin drives striatal synaptic plasticity in a sex-related manner 70
Theta-burst stimulation and striatal plasticity in experimental parkinsonism 69
Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias 68
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment 68
The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D-2/A(2A) Receptor Interaction in the Striatum: Implications for Parkinson's Disease 68
l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation. 67
A positive allosteric modulator of mGlu4 receptors restores striatal plasticity in an animal model of L-Dopa-induced dyskinesia 66
Transcranial Magnetic Stimulation Exerts "Rejuvenation" Effects on Corticostriatal Synapses after Partial Dopamine Depletion 66
Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia 65
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease 65
Prenatal stress and hippocampal BDNF expression: a fading imperative 65
Intensive exercise ameliorates motor and cognitive symptoms in experimental Parkinson's disease restoring striatal synaptic plasticity 65
Striatum-hippocampus balance: From physiological behavior to interneuronal pathology 64
Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. 64
Reply to: Rewiring Brains in Parkinson's Disease: The New Era of Brain Stimulation 63
L-DOPA reverses the impairment of Dentate Gyrus LTD in experimental parkinsonism via beta-adrenergic receptors 63
Effects of uremic toxins on hippocampal synaptic transmission: implication for neurodegeneration in chronic kidney disease 63
Environmental enrichment restores CA1 hippocampal LTP and reduces severity of seizures in epileptic mice 62
Derangement of Ras-Guanine Nucleotide-Releasing Factor 1 (Ras-GRF1) and Extracellular Signal-Regulated Kinase (ERK) Dependent Striatal Plasticity in L-DOPA-Induced Dyskinesia 62
Memantine alters striatal plasticity inducing a shift of synaptic responses toward long-term depression 62
Alpha-synuclein and cortico-striatal plasticity in animal models of Parkinson disease 61
Dopamine-Dependent Long-Term Depression Is Expressed in Striatal Spiny Neurons of Both Direct and Indirect Pathways: Implications for Parkinson's Disease 61
Dopamine-dependent early synaptic and motor dysfunctions induced by a-synuclein in the nigrostriatal circuit 60
Neural networks and synaptic plasticity in Parkinson's disease: beyond motor deficits 59
Hyperkinetic disorders and loss of synaptic downscaling 59
FUNCTIONAL INTERACTIONS WITHIN STRIATAL MICROCIRCUIT IN ANIMAL MODELS OF HUNTINGTON'S DISEASE 58
Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice. 58
mTOR inhibitor rapamycin suppresses striatal post-ischemic LTP 58
Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? 57
Environmental Enrichment and Functional Plasticity in the Hippocampus – An Update on the Mechanisms Involved 57
Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction 56
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 56
Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition 56
Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia 55
Molecular mechanisms underlying levodopa-induced dyskinesia. 55
Plastic abnormalities in experimental Huntington's disease 55
Attachment and parental reflective functioning features in ADHD: Enhancing the knowledge on parenting characteristics 54
"Lazy" nigrostriatal synapses in the heterozygous PINK1 mouse model of familial Parkinson's disease 54
L-3,4-Dihydroxyphenylalanine-Induced Sprouting of Serotonin Axon Terminals: A Useful Biomarker for Dyskinesias? 54
Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons 54
The endocannabinoid system in Parkinson's disease. 53
CalDAG-GEFI mediates striatal cholinergic modulation of dendritic excitability, synaptic plasticity and psychomotor behaviors 53
Assemblies of glutamate receptor subunits with post-synaptic density proteins and their alterations in Parkinson's disease 52
Astrocyte Responses Influence Local Effects of Whole‐Brain Magnetic Stimulation in Parkinsonian Rats 52
Striatal synaptic changes in experimental parkinsonism: role of NMDA receptor trafficking in PSD. 52
Rebalance of Striatal NMDA/AMPA Receptor Ratio Underlies the Reduced Emergence of Dyskinesia During D2-Like Dopamine Agonist Treatment in Experimental Parkinson's Disease 52
Cigarette smoke inhalation stimulates dopaminergic neurons in rats 51
Sarcopenia and Cognitive Decline in Older Adults: Targeting the Muscle-Brain Axis 51
Long-Term Shaping of Corticostriatal Synaptic Activity by Acute Fasting 51
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease 50
Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion 50
Intermittent Theta-burst Stimulation Rescues Dopamine-Dependent Corticostriatal Synaptic Plasticity and Motor Behavior in Experimental Parkinsonism: Possible Role of Glial Activity 50
Striatal glutamatergic hyperactivity in Parkinson's disease 49
Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson’s Disease 49
Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease 48
Impairment of long term depression in dyskinetic rats: A critical role of NO/cGMP pathway in recovering synaptic plasticity 47
Short-term and long-term plasticity at corticostriatal synapses: implications for learning and memory 46
Direct and indirect pathways in levodopa-induced dyskinesia: a more complex matter than a network imbalance. 46
Effects of safinamide on the glutamatergic striatal network in experimental Parkinson's disease 46
Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons 46
Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: electrophysiological evidence 45
Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits 45
Alpha-synuclein: From early synaptic dysfunction to neurodegeneration 43
Neurofunctional effects of developmental alcohol exposure in alcohol-preferring and alcohol-nonpreferring rats 41
Advances in understanding the function of alpha-synuclein: implications for Parkinson’s disease 41
Le emozioni nei contesti individuali e sociali 41
Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced Dyskinesia 41
Reply to: Rewiring Brains in Parkinson's Disease: The New Era of Brain Stimulation 38
Synaptic dysfunction in Parkinson's disease 38
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 38
Environmental enrichment repairs structural and functional plasticity in the hippocampus 37
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease 35
Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release 35
Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat 34
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 34
Neuro-Immune Cross-Talk in the Striatum: From Basal Ganglia Physiology to Circuit Dysfunction 32
Rhes, a key element of selective neuronal vulnerability in Huntington's disease: a striatal-specific license to kill during energy metabolism failure 32
Repetitive transcranial magnetic stimulation reduces remote apoptotic cell death and inflammation after focal brain injury 31
TrkB/BDNF-dependent striatal plasticity and behavior in a genetic model of epilepsy: modulation by valproic acid 31
Hippocampal enlargement in Bassoon-mutant mice is associated with enhanced neurogenesis, reduced apoptosis, and abnormal BDNF levels 30
Maternal stress programs accelerated aging of the basal ganglia motor system in offspring 29
Backtracking α-synuclein pathology: social deficits precede motor symptoms in Parkinson’s disease 26
Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit 26
Synaptic Interactions Between Serotonergic and Dopaminergic Systems in Parkinson’s Disease 23
Totale 5.493
Categoria #
all - tutte 50.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.590


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022497 0 141 143 0 3 7 18 50 27 92 9 7
2022/2023336 178 2 3 20 30 6 4 8 15 21 40 9
2023/2024252 0 2 11 60 8 7 1 3 8 25 20 107
2024/2025868 36 205 46 21 40 148 26 76 102 13 42 113
2025/20262.465 203 190 223 221 163 251 359 178 213 368 58 38
2026/2027269 30 239 0 0 0 0 0 0 0 0 0 0
Totale 5.493